Bridgefront Capital, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 172 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bridgefront Capital, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$157,000
+28.7%
24,396
+16.5%
0.15%
+19.7%
Q3 2021$122,000
-69.0%
20,946
-44.0%
0.13%
+4.1%
Q1 2021$393,000
+69.4%
37,381
+149.3%
0.12%
+54.4%
Q4 2020$232,00014,9930.08%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,827,078$82,205,0004.43%
Palo Alto Investors LP 4,663,324$79,416,0003.21%
Private Capital Advisors, Inc. 473,901$8,071,0002.23%
DOHENY ASSET MANAGEMENT /CA 215,445$3,669,0001.92%
Sandia Holdings, LLC 119,739$2,039,0000.96%
Capital Impact Advisors, LLC 102,006$1,744,0000.60%
Birchview Capital, LP 50,000$852,0000.55%
EMERALD ADVISERS, LLC 694,068$11,820,0000.43%
EMERALD MUTUAL FUND ADVISERS TRUST 647,307$11,024,0000.37%
Schonfeld Strategic Advisors LLC 418,100$7,121,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders